BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lung cancer AND DDX3X, DDX14, 1654, ENSG00000215301, DBX, DDX3, HLP2 AND Treatment
7 results:

  • 1. Significance of miR-15a-5p and CNKSR3 as Novel Prognostic Biomarkers in Non-Small Cell lung cancer.
    Ergun S; Güney S; Temiz E; Petrovic N; Gunes S
    Anticancer Agents Med Chem; 2018; 18(12):1695-1701. PubMed ID: 30019650
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Genomic profiling of malignant peritoneal mesothelioma reveals recurrent alterations in epigenetic regulatory genes BAP1, SETD2, and ddx3x.
    Joseph NM; Chen YY; Nasr A; Yeh I; Talevich E; Onodera C; Bastian BC; Rabban JT; Garg K; Zaloudek C; Solomon DA
    Mod Pathol; 2017 Feb; 30(2):246-254. PubMed ID: 27813512
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. ddx3, a potential target for cancer treatment.
    Bol GM; Xie M; Raman V
    Mol Cancer; 2015 Nov; 14():188. PubMed ID: 26541825
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. RNA helicase ddx3: a novel therapeutic target in Ewing sarcoma.
    Wilky BA; Kim C; McCarty G; Montgomery EA; Kammers K; DeVine LR; Cole RN; Raman V; Loeb DM
    Oncogene; 2016 May; 35(20):2574-83. PubMed ID: 26364611
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Targeting ddx3 with a small molecule inhibitor for lung cancer therapy.
    Bol GM; Vesuna F; Xie M; Zeng J; Aziz K; Gandhi N; Levine A; Irving A; Korz D; Tantravedi S; Heerma van Voss MR; Gabrielson K; Bordt EA; Polster BM; Cope L; van der Groep P; Kondaskar A; Rudek MA; Hosmane RS; van der Wall E; van Diest PJ; Tran PT; Raman V
    EMBO Mol Med; 2015 May; 7(5):648-69. PubMed ID: 25820276
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. ddx3x induces primary EGFR-TKI resistance based on intratumor heterogeneity in lung cancer cells harboring EGFR-activating mutations.
    Nozaki K; Kagamu H; Shoji S; Igarashi N; Ohtsubo A; Okajima M; Miura S; Watanabe S; Yoshizawa H; Narita I
    PLoS One; 2014; 9(10):e111019. PubMed ID: 25343452
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. DEAD/H (Asp-Glu-Ala-Asp/His) box polypeptide 3, X-linked is an immunogenic target of cancer stem cells.
    Koshio J; Kagamu H; Nozaki K; Saida Y; Tanaka T; Shoji S; Igarashi N; Miura S; Okajima M; Watanabe S; Yoshizawa H; Narita I
    Cancer Immunol Immunother; 2013 Oct; 62(10):1619-28. PubMed ID: 23974721
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.